This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of torsemide: A Synthesis of Findings from 21 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of torsemide: A Synthesis of Findings from 21 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Torsemide, a loop diuretic, has shown to have longer and more potent diuretic and natriuretic effects compared to furosemide in short-term studies. 1 However, its long-term effects and complications are not fully understood yet. 1 In patients with acute heart failure, torsemide has been shown to be associated with similar outcomes to furosemide in unadjusted analysis, but with nominally lower events in adjusted analysis. 10 Despite the limited evidence, some studies have suggested potential advantages of torsemide in improving heart failure management. 17

Torsemide has demonstrated efficacy in managing congestive heart failure in dogs. 12 While the use of torsemide in cats with spontaneous CHF is less well-established, a retrospective study documented its therapeutic use and potential adverse effects. 12 Torsemide has been evaluated for its impact on warfarin therapy in both humans and rats. In rats, high doses of torsemide were found to increase the pharmacodynamic response of warfarin. 20 In humans, a retrospective study suggested a potential interaction with warfarin, potentially leading to the need for dose adjustments. 20 3

A meta-analysis comparing torsemide to furosemide in patients with heart failure revealed that torsemide was associated with a numerical reduction in heart failure hospitalization, a statistically significant improvement in functional status, and a lower risk of cardiac mortality. 8 However, there was no significant difference in all-cause mortality or medication side effects. 8 A separate meta-analysis of 10 randomized controlled trials found that torsemide was associated with a reduced risk of hospitalizations compared to furosemide, without any difference in mortality. 5

Benefits and Risks

Benefits Summary

Torsemide appears to offer potential benefits in managing heart failure, including a lower risk of hospitalizations and improved functional status. 8 5

Risks Summary

Torsemide may have a greater impact on the cardiovascular system compared to furosemide, requiring careful monitoring and potential dose adjustments. 5 Furthermore, torsemide may increase the risk of renal dysfunction and interact with warfarin, leading to increased bleeding risk. 20 3

Comparison Across Studies

Similarities Across Studies

Several studies consistently demonstrate that torsemide provides longer and more potent diuretic and natriuretic effects compared to furosemide. 1 17 8

Differences Across Studies

While some studies suggest a potentially greater impact on the cardiovascular system with torsemide, 5 others highlight a potential benefit in reducing the risk of atrial fibrillation and a safer profile compared to furosemide. 8 The optimal choice between torsemide and furosemide may vary depending on individual patient factors and their specific needs.

Consistency and Contradictions

There are some contradictions in the findings regarding the cardiovascular impact of torsemide. While certain studies point to a greater risk, 5 other research suggests a lower risk of atrial fibrillation and a safer profile compared to furosemide. 8 Further research is needed to clarify these inconsistencies and establish the optimal choice between torsemide and furosemide.

Real-World Application Considerations

When considering torsemide, it is crucial to be aware of its potential impact on the cardiovascular system and the possibility of increased risk of renal dysfunction and interactions with other medications like warfarin. 20 3 5 Close monitoring and careful consideration of individual patient factors are essential when using torsemide.

Limitations of Current Research

Several limitations exist in the existing research on torsemide, including the relatively small sample sizes of some studies, the lack of long-term follow-up, and the non-randomized selection of patients in some cases. 10 6 17 8 Larger, longer-term, randomized controlled trials are needed to provide more definitive evidence on the benefits and risks of torsemide compared to furosemide.

Future Research Directions

Large-scale, long-term, randomized controlled trials are necessary to provide conclusive evidence on the efficacy and safety of torsemide in comparison to furosemide. 17 8 Furthermore, research is needed to evaluate the effects of torsemide in patients with varying heart failure severity and comorbidities. 10 6

Conclusion

Torsemide shows promise as a potent loop diuretic with potential benefits for patients with heart failure, including reduced hospitalizations and improved functional status. 8 5 However, it is essential to carefully consider the potential risks associated with torsemide, including its impact on the cardiovascular system and the potential for drug interactions. 20 3 5 Further research is needed to provide a more definitive understanding of torsemide's effects and to determine its optimal use in clinical practice.


Literature analysis of 21 papers
Positive Content
17
Neutral Content
1
Negative Content
3
Article Type
3
2
1
4
21

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: MentzRobert J, HasselbladVic, DeVoreAdam D, MetraMarco, VoorsAdriaan A, ArmstrongPaul W, EzekowitzJustin A, TangW H Wilson, SchultePhillip J, AnstromKevin J, HernandezAdrian F, VelazquezEric J, O'ConnorChristopher M


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.